Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Thaventhiran, JED"'
Autor:
Karyn Megy, William Rae, Thaventhiran Jed., A Herwadkar, Paul Tuijnenburg, S Grigoriadou, Oliver S. Burren, Christopher J. Penkett, Zinan Zhang, Daniel Greene, Sinisa Savic, Willem H. Ouwehand, Matthew E. Hurles, Deevi Svv., Edgar Jdm., Crina Samarghitean, A Worth, Nicholas Gleadall, David Ellinghaus, Taco W. Kuijpers, Tom H. Karlsen, H Lango Allen, Catharina Schuetz, Pavels Gordins, Antony J. Cutler, Jesmeen Maimaris, Smith Kgc., David M. Sansom, Steven Hanson, Jonathan Stephens, Paul A. Lyons, Paula Rayner-Matthews, Kathleen Stirrups, Alba Sanchis-Juan, Adrian J. Thrasher, Anita Chandra, Andy G. Lynch, E Rivers, Siobhan O. Burns, Matthew A. Brown, Rachel Linger, Ilenia Simeoni, Eva Ellinghaus, Kimberly Gilmour, Ravishankar Sargur, Farmery Jhr., Matthew Buckland, Aarnoud Huissoon, Sarah Goddard, Dinakantha S. Kumararatne, Emily Staples, Ernest Turro, Helen Baxendale, Moira Thomas, Silje F. Jørgensen, Stephen Jolles, Suranjith L. Seneviratne, F Boschann, Neill S. Cooper
Publikováno v:
Nature. 584:E2-E2
Autor:
Sng, CCT, O’Byrne, S, Prigozhin, DM, Bauer, MR, Harvey, JC, Ruhle, M, Challis, BG, Lear, S, Roberts, LD, Workman, S, Janowitz, T, Magiera, L, Doffinger, R, Buckland, MS, Jodrell, DJ, Semple, RK, Wilson, TJ, Modis, Y, Thaventhiran, JED
Publikováno v:
The Journal of Allergy and Clinical Immunology
Sng, C C T, O'Byrne, S, Prigozhin, D M, Bauer, M R, Harvey, J C, Ruhle, M, Challis, B G, Lear, S, Roberts, L D, Workman, S, Janowitz, T, Magiera, L, Doffinger, R, Buckland, M S, Jodrell, D J, Semple, R K, Wilson, T J, Modis, Y & Thaventhiran, J E D 2018, ' A type III complement factor D deficiency : Structural insights for inhibition of the alternative pathway ', Journal of Allergy and Clinical Immunology . https://doi.org/10.1016/j.jaci.2018.01.048
The Journal of allergy and clinical immunology, vol 142, iss 1
Sng, Christopher CT; O'Byrne, Sorcha; Prigozhin, Daniil M; Bauer, Matthias R; Harvey, Jennifer C; Ruhle, Michelle; et al.(2018). A type III complement factor D deficiency: Structural insights for inhibition of the alternative pathway.. The Journal of allergy and clinical immunology, 142(1), 311-314.e6. doi: 10.1016/j.jaci.2018.01.048. Lawrence Berkeley National Laboratory: Retrieved from: http://www.escholarship.org/uc/item/9j831648
Sng, C C T, O'Byrne, S, Prigozhin, D M, Bauer, M R, Harvey, J C, Ruhle, M, Challis, B G, Lear, S, Roberts, L D, Workman, S, Janowitz, T, Magiera, L, Doffinger, R, Buckland, M S, Jodrell, D J, Semple, R K, Wilson, T J, Modis, Y & Thaventhiran, J E D 2018, ' A type III complement factor D deficiency : Structural insights for inhibition of the alternative pathway ', Journal of Allergy and Clinical Immunology . https://doi.org/10.1016/j.jaci.2018.01.048
The Journal of allergy and clinical immunology, vol 142, iss 1
Sng, Christopher CT; O'Byrne, Sorcha; Prigozhin, Daniil M; Bauer, Matthias R; Harvey, Jennifer C; Ruhle, Michelle; et al.(2018). A type III complement factor D deficiency: Structural insights for inhibition of the alternative pathway.. The Journal of allergy and clinical immunology, 142(1), 311-314.e6. doi: 10.1016/j.jaci.2018.01.048. Lawrence Berkeley National Laboratory: Retrieved from: http://www.escholarship.org/uc/item/9j831648
Background: Complement factor D (FD) is the rate-limiting enzyme of the alternative complement pathway. Previous reports of FD deficiency featured absent plasma FD (type I deficiency) and susceptibility to meningococcal infection. A new FD mutant, wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3b02c12330f21d271d04b9136ea250fb
https://eprints.whiterose.ac.uk/128452/8/1-s2.0-S0091674918303270-main.pdf
https://eprints.whiterose.ac.uk/128452/8/1-s2.0-S0091674918303270-main.pdf
Autor:
Thaventhiran, JED
Background: The genetic etiology of primary immunodeficiency disease (PID) carries prognostic information.Objective: We conducted a whole-genome sequencing study assessing a large proportion of the NIHR- BioResource – Rare Disease cohort. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aac62884f21274c97b122bc9e33c23c9
Autor:
Staples, E, Morillo-Gutierrez, B, Davies, J, Petersheim, D, Massaad, M, Slatter, M, Dimou, D, Doffinger, R, Hackett, S, Kumararatne, D, Hadfield, J, Eldridge, MD, Geha, RS, Abinun, M, Thaventhiran, JED
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::729f4f179793bac66a89cbd55150a758
https://www.repository.cam.ac.uk/handle/1810/264120
https://www.repository.cam.ac.uk/handle/1810/264120
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fischer K; Department of Biochemistry, University of Cambridge, Cambridge, UK., Lulla A; Department of Biochemistry, University of Cambridge, Cambridge, UK., So TY; MRC Toxicology Unit, Gleeson Building, Cambridge, UK., Pereyra-Gerber P; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK., Raybould MIJ; Oxford Protein Informatics Group, Department of Statistics, University of Oxford, Oxford, UK., Kohler TN; Department of Biochemistry, University of Cambridge, Cambridge, UK., Yam-Puc JC; MRC Toxicology Unit, Gleeson Building, Cambridge, UK., Kaminski TS; Department of Biochemistry, University of Cambridge, Cambridge, UK.; Department of Molecular Biology, Institute of Biochemistry, Faculty of Biology, University of Warsaw, Warsaw, Poland., Hughes R; MRC Toxicology Unit, Gleeson Building, Cambridge, UK., Pyeatt GL; Department of Biochemistry, University of Cambridge, Cambridge, UK., Leiss-Maier F; Department of Biochemistry, University of Cambridge, Cambridge, UK., Brear P; Department of Biochemistry, University of Cambridge, Cambridge, UK., Matheson NJ; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK.; NHS Blood and Transplant, Cambridge, UK., Deane CM; Oxford Protein Informatics Group, Department of Statistics, University of Oxford, Oxford, UK., Hyvönen M; Department of Biochemistry, University of Cambridge, Cambridge, UK., Thaventhiran JED; MRC Toxicology Unit, Gleeson Building, Cambridge, UK. jedt2@mrc-tox.cam.ac.uk., Hollfelder F; Department of Biochemistry, University of Cambridge, Cambridge, UK. fh111@cam.ac.uk.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2024 Aug 14. Date of Electronic Publication: 2024 Aug 14.
Autor:
Takahashi M; Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK.; Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Tokyo 113-0033, Japan., So TY; Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK.; University of Cambridge, CRUK Cambridge Institute, Cambridge CB2 0RE, UK., Chamberlain-Evans V; Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK., Hughes R; Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK., Yam-Puc JC; Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK., Kania K; University of Cambridge, CRUK Cambridge Institute, Cambridge CB2 0RE, UK., Ruhle M; University of Cambridge, CRUK Cambridge Institute, Cambridge CB2 0RE, UK., Mann T; Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK., Schuijs MJ; University of Cambridge, CRUK Cambridge Institute, Cambridge CB2 0RE, UK., Coupland P; University of Cambridge, CRUK Cambridge Institute, Cambridge CB2 0RE, UK.; Altos Labs Cambridge Institute, Cambridge CB21 6GP, UK., Naisbitt D; Department of Pharmacology and Therapeutics, University of Liverpool, Sherrington Building, Ashton Street, Liverpool L69 3G, UK., Halim TYF; University of Cambridge, CRUK Cambridge Institute, Cambridge CB2 0RE, UK., Lyons PA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge, School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK., Lio P; Department of Computer Science and Technology, University of Cambridge, Cambridge CB3 0FD, UK., Roychoudhuri R; Department of Pathology, University of Cambridge, Cambridge, UK., Okkenhaug K; Department of Pathology, University of Cambridge, Cambridge, UK., Adams DJ; Experimental Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK., Smith KGC; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge, School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.; Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.; University of Melbourne, Parkville, VIC 3052, Australia., Jodrell DI; Department of Oncology, University of Cambridge, School of Clinical Medicine, Cambridge Biomedical Campus, Box 197, Cambridge CB2 0XZ, UK., Chapman MA; Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK.; Department of Hematology, University of Cambridge, Cambridge CB2 0RE, UK., Thaventhiran JED; Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK.; University of Cambridge, CRUK Cambridge Institute, Cambridge CB2 0RE, UK.
Publikováno v:
Science immunology [Sci Immunol] 2024 May 24; Vol. 9 (95), pp. eade2094. Date of Electronic Publication: 2024 May 24.
Autor:
Mulroney TE; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Pöyry T; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Yam-Puc JC; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Rust M; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Harvey RF; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Kalmar L; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Horner E; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Booth L; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Ferreira AP; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Stoneley M; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Sawarkar R; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Mentzer AJ; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK., Lilley KS; Department of Biochemistry, University of Cambridge, Cambridge, UK., Smales CM; School of Biosciences, Division of Natural Sciences, University of Kent, Canterbury, UK.; National Institute for Bioprocessing Research and Training, University College Dublin, Foster Avenue, Mount Merrion, Dublin, Ireland., von der Haar T; School of Biosciences, Division of Natural Sciences, University of Kent, Canterbury, UK., Turtle L; NIHR Health Protection Research Unit for Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK., Dunachie S; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; NDM Centre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand., Klenerman P; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Thaventhiran JED; MRC Toxicology Unit, University of Cambridge, Cambridge, UK. jedt2@cam.ac.uk., Willis AE; MRC Toxicology Unit, University of Cambridge, Cambridge, UK. aew80@cam.ac.uk.
Publikováno v:
Nature [Nature] 2024 Jan; Vol. 625 (7993), pp. 189-194. Date of Electronic Publication: 2023 Dec 06.
Autor:
Ferreira IATM; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., Lee CYC; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK; Cellular Genetics, Wellcome Sanger Institute, Cambridge, UK., Foster WS; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridge, UK., Abdullahi A; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., Dratva LM; Cellular Genetics, Wellcome Sanger Institute, Cambridge, UK., Tuong ZK; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK; Cellular Genetics, Wellcome Sanger Institute, Cambridge, UK., Stewart BJ; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK; Cellular Genetics, Wellcome Sanger Institute, Cambridge, UK., Ferdinand JR; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK., Guillaume SM; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridge, UK., Potts MOP; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., Perera M; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., Krishna BA; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., Peñalver A; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK., Cabantous M; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK., Kemp SA; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Cambridge University Hospital NHS Trust, Cambridge, UK., Ebrahimi S; Department of Clinical Biochemistry and Immunology, Cambridge University Hospital NHS Trust, Cambridge, UK., Lyons P; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., Smith KGC; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., Bradley J; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., Collier DA; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., McCoy LE; Division of Infection and Immunity, UCL, London, UK., van der Klaauw A; University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome-Medical Research Council (MRC) Institute of Metabolic Science, Cambridge, UK., Thaventhiran JED; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Farooqi IS; University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome-Medical Research Council (MRC) Institute of Metabolic Science, Cambridge, UK., Teichmann SA; Cellular Genetics, Wellcome Sanger Institute, Cambridge, UK., MacAry PA; National University of Singapore, Singapore, Singapore., Doffinger R; Department of Clinical Biochemistry and Immunology, Cambridge University Hospital NHS Trust, Cambridge, UK., Wills MR; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., Linterman MA; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridge, UK. Electronic address: michelle.linterman@babraham.ac.uk., Clatworthy MR; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK; Cellular Genetics, Wellcome Sanger Institute, Cambridge, UK. Electronic address: mrc38@medschl.cam.ac.uk., Gupta RK; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK. Electronic address: rkg20@cam.ac.uk.
Publikováno v:
Cell reports [Cell Rep] 2023 Aug 29; Vol. 42 (8), pp. 112991. Date of Electronic Publication: 2023 Aug 16.
Autor:
Graziano V; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK vincenzo.graziano@astrazeneca.com Duncan.Jodrell@cruk.cam.ac.uk.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK., Dannhorn A; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences (CPSS), AstraZeneca R&D, Cambridge, UK., Hulme H; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences (CPSS), AstraZeneca R&D, Cambridge, UK., Williamson K; Medical Research Council Toxicology Unit, University of Cambridge, Cambridge, UK., Buckley H; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Karim SA; Cancer Research UK Beatson Institute, Glasgow, UK., Wilson M; Oncology R&D, Research and Early Development, AstraZeneca R&D, Cambridge, UK., Lee SY; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Kaistha BP; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Islam S; Department of Oncology, University of Cambridge, Cambridge, UK., Thaventhiran JED; Medical Research Council Toxicology Unit, University of Cambridge, Cambridge, UK., Richards FM; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Goodwin R; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences (CPSS), AstraZeneca R&D, Cambridge, UK., Brais R; Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Morton JP; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Dovedi SJ; Oncology R&D, Research and Early Development, AstraZeneca R&D, Cambridge, UK., Schuller AG; Oncology, AstraZeneca R&D Boston, Waltham, Massachusetts, USA., Eyles J; Oncology R&D, Research and Early Development, AstraZeneca R&D, Cambridge, UK., Jodrell DI; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK vincenzo.graziano@astrazeneca.com Duncan.Jodrell@cruk.cam.ac.uk.; Department of Oncology, University of Cambridge, Cambridge, UK.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Aug; Vol. 11 (8).